Artificial Intelligence in Infectious Disease Clinical Practice: An Overview of Gaps, Opportunities, and Limitations
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
The integration of artificial intelligence (AI) in clinical medicine marks a revolutionary shift, enhancing diagnostic accuracy, therapeutic efficacy, and overall healthcare delivery. This review explores the current uses, benefits, limitations, and future applications of AI in infectious diseases, highlighting its specific applications in diagnostics, clinical decision making, and personalized medicine. The transformative potential of AI in infectious diseases is emphasized, addressing gaps in rapid and accurate disease diagnosis, surveillance, outbreak detection and management, and treatment optimization. Despite these advancements, significant limitations and challenges exist, including data privacy concerns, potential biases, and ethical dilemmas. The article underscores the need for stringent regulatory frameworks and inclusive databases to ensure equitable, ethical, and effective AI utilization in the field of clinical and laboratory infectious diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Its modular and adaptable design supports broad generalizability across diverse clinical domains beyond cardiovascular diagnoses, such as oncology, neurology, and infectious diseases [37,38,39].”
From Enhancing Clinician Trust in AI Diagnostics: A Dynamic Framework for Confidence Calibration and Transparency (2025) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kumar, Y., Koul, A., Singla, R., & Ijaz, M. F. (2023) · Journal of Ambient Intelligence and Humanized Computing · doi:10.1007/s12652-021-03612-z · Cited by 1,040 · cited 4×
“There was a sensitivity of 91% and specificity of 65% in meta-analysis of 23 There was a sensitivity of 91% and specificity of 65% in a meta-analysis of 23 clinical studies with a total of 124,959 patients [30]. studies with a total of 124,959 patients [30].”
BackgroundMethodInfluentialRetractedRajkomar, A., Dean, J., & Kohane, I. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1814259 · Cited by 4,579 · cited 3×
“There was a sensitivity of 91% and specificity of 65% in meta-analysis of 23 There was a sensitivity of 91% and specificity of 65% in a meta-analysis of 23 clinical studies with a total of 124,959 patients [30]. studies with a total of 124,959 patients [30].”
BackgroundMethodLarge language models in medicine
Thirunavukarasu, A. J., Ting, D. S. J., Elangovan, K., Gutierrez, L., Tan, T. F., & Ting, D. S. W. (2023) · Nature Medicine · doi:10.1038/s41591-023-02448-8 · Cited by 3,944
Sarker, I. H. (2021) · SN Computer Science · doi:10.1007/s42979-021-00815-1 · Cited by 2,678
Big Data and Machine Learning in Health Care
Beam, A. L., & Kohane, I. S. (2018) · JAMA · doi:10.1001/jama.2017.18391 · Cited by 2,506 · cited 1×
“This tends to enhance early intervention strategies while optimizing the utilization of resources [34].”
BackgroundA Deep Learning Approach to Antibiotic Discovery
Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.021 · Cited by 2,463
Artificial intelligence in medicine
Hamet, P., & Tremblay, J. (2017) · Metabolism · doi:10.1016/j.metabol.2017.01.011 · Cited by 2,334
Overview of artificial intelligence in medicine
Amisha, Malik, P., Pathania, M., & Rathaur, V. K. (2019) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_440_19 · Cited by 1,106 · cited 1×
“The advent of artificial intelligence (AI) has heralded a transformative era in clinical medicine, offering opportunities to enhance diagnostic speed and accuracy, optimize therapeutic efficacy, and benefit healthcare in general [1].”
BackgroundRedefining Radiology: A Review of Artificial Intelligence Integration in Medical Imaging
Najjar, R. (2023) · Diagnostics · doi:10.3390/diagnostics13172760 · Cited by 886
Digital disease detection - harnessing the Web for public health surveillance
Brownstein, J. S., Freifeld, C. C., & Madoff, L. C. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0900702 · Cited by 819
Research works printed but not linked: 2
- Yu, Z., Li, Y., Kim, J., Huang, K., Luo, Y., and Wang, M. (2023). Deep Reinforcement Learning for Cost-Effective Medical Diagnosis. arXiv.
- Barh, D. (2020). Chapter 18—Use of Artificial Intelligence in Infectious Diseases. Artificial Intelligence in Precision Health, Academic Press.
Cited by
Machine learning for extracellular vesicles enables diagnostic and therapeutic nanobiotechnology
Tiwari, A. K., Widodo, Krisnawati, D. I., Tzou, K.-Y., & Kuo, T. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03952-4 · Cited by 60
Artificial intelligence and infectious disease diagnostics: state of the art and future perspectives
Miglietta, L., Rawson, T. M., Galiwango, R. M., Tasker, A. J., Ming, D. K. Y., Akogo, D., Ferreyra, C., Aboagye, E. O., Gordon, N. C., García‐Vidal, C., et al. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00354-8 · Cited by 53
Vargas-Santiago, M., León-Velasco, D. A., Maldonado-Sifuentes, C. E., & Chanona-Hernández, L. (2025) · Computers · doi:10.3390/computers14040143 · Cited by 47
Assudani, P. J., Bhurgy, A. S., Kollem, S., Bhurgy, B. S., Ahmad, M. O., Kulkarni, M. B., & Bhaiyya, M. L. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.115802 · Cited by 43
Kajornkasirat, S., Sawangwong, C., Puangsuwan, K., Chanapai, N., Phutthamongkhon, W., & Puttinaovarat, S. (2025) · Applied Sciences · doi:10.3390/app15084400 · Cited by 42
Metadata
- Authors
- Sarantopoulos, A., Mastori Kourmpani, C., Yokarasa, A. L., Makamanzi, C., Antoniou, P., Spernovasilis, N., & Tsioutis, C.
- Affiliations
- Brigham and Women's Hospital (US)
- School of Medicine, European University of Cyprus, 2404 Nicosia, Cyprus
- European University Cyprus (CY)
- University of Crete (GR)
- Corresponding author
- Tsioutis, Constantinos
- ORCID
- Venue
- Tropical Medicine and Infectious Disease
- Publisher
- MDPI AG
- Published
- 2024-09-30
- Volume
- 9
- Issue
- 10
- Pages
- 228
- ISSN
- 2414-6366 (ISSN-L)
- PMC
- PMC11511260
- OpenAlex
- W4402996938
- Cited by
- 40
- References
- 54
- Citations by year
- 2026: 11 · 2025: 28 · 2024: 1
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Tropical Medicine and Infectious Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Physical Sciences › Computer Science › Artificial Intelligence › Artificial Intelligence Applications
- Keywords
- artificial intelligence, infectious diseases, diagnosis, clinical decision-making, personalized medicine, outbreak detection, disease surveillance, treatment optimization, data privacy, algorithmic bias, AI ethics, regulatory framework, laboratory diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Artificial Intelligence in Infectious Disease Clinical Practice: An Overview of Gaps, Opportunities, and Limitations. https://app.cochat.ai/papers/10.3390/tropicalmed9100228
- The paper
- Sarantopoulos, A., Mastori Kourmpani, C., Yokarasa, A. L., Makamanzi, C., Antoniou, P., Spernovasilis, N., & Tsioutis, C. (2024). Artificial Intelligence in Infectious Disease Clinical Practice: An Overview of Gaps, Opportunities, and Limitations. Tropical Medicine and Infectious Disease. https://doi.org/10.3390/tropicalmed9100228
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

